| 摘要 |
The present invention is directed to a method for the treatment of cancer via the administration of a pharmaceutical composition, comprising at least one compound of formula (I) or a pharmaceutically acceptable salt of compound (I), in combination with capecitabine, trastuzumab, pertuzumab, cisplatin or irinotecan, or a pharmaceutically acceptable salt thereof, for simultaneous, sequential or separated administration in the treatment of cancer. |
